Related Articles
CHD1L is associated with poor survival and promotes the proliferation and metastasis of intrahepatic cholangiocarcinoma Corrigendum in /10.3892/or.2019.7262
Patients with normal‑range CA19‑9 levels represent a distinct subgroup of pancreatic cancer patients
Carbohydrate antigen 19‑9 as a prognostic biomarker in pancreatic neuroendocrine tumors
Knockdown of cullin 3 inhibits progressive phenotypes and increases chemosensitivity in cholangiocarcinoma cells
Clinical significance of mismatch repair gene expression in sporadic colorectal cancer